Breaking News Instant updates and real-time market news.

MNST

Monster Beverage

$57.87

-2.72 (-4.49%)

05:07
03/20/19
03/20
05:07
03/20/19
05:07

Monster Beverage downgraded to Neutral from Conviction Buy at Goldman Sachs

Goldman Sachs analyst Judy Hong downgraded Monster Beverage to Neutral from Buy and removed the shares from her firm's Americas Conviction List. She also lowered her price target for the stock to $59 from $67. Monster closed yesterday down 4%, or $2.68, to $57.92. The company's U.S. sales could remain softer than expected in the near term, driving downward estimate revisions, Hong tells investors in a research note. Recent Nielsen data points to a "sizable slowing" in Monster's sales growth, says the analyst. She thinks heightened competition from Red Bull and continued growth from Bang are beginning to have a more sizable market share and sales impact on the company.

MNST Monster Beverage
$57.87

-2.72 (-4.49%)

03/07/19
03/07/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Five Below (FIVE) initiated with an Outperform at Oppenheimer. 2. Teva (TEVA) reinstated with a Buy at UBS. 3. Chiasma (CHMA) initiated with an Overweight at Cantor Fitzgerald. 4. Monster Beverage (MNST) and Constellation Brands (STZ) were initiated with an Outperform at Credit Suisse, while Procter & Gamble (PG), Coca-Cola (KO), and Church & Dwight (CHD) were initiated with a Neutral, and PepsiCo (PEP), Colgate-Palmolive (CL), and Clorox (CLX) initiated with an Underperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/11/19
STFL
03/11/19
NO CHANGE
Target $67
STFL
Buy
Hypothetical Bang sale more negative than positive for Monster, says Stifel
Stifel analyst Mark Astrachan examined the hypothetical impact on Monster Beverage (MNST) should a larger beverages competitor acquire Bang, though he noted he has no knowledge of M&A negotiations or discussions with the energy drink competitor. He ultimately concluded a potential acquisition of Bang would be more negative than positive for Monster, though he also noted that risks of an acquisition include potential disruption of Bang's recent momentum, especially if it were to be acquired by PepsiCo (PEP) and transition distribution most likely in-house from the AB InBev (BUD) system. Additionally, a theoretical Bang deal could accelerate a decision by Coca-Cola (KO) regarding acquiring, or not, the remaining shares in Monster it does not currently own, said Astrachan, who keeps a Buy rating and $67 price target on Monster Beverage shares.
03/12/19
BMOC
03/12/19
DOWNGRADE
Target $62
BMOC
Market Perform
Monster Beverage downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Amit Sharma downgraded Monster Beverage (MNST) to Market Perform from Outperform with an unchanged price target of $62. The stock closed yesterday up 58c to $61.19. Monster's current valuation, both absolute and relative to peers, "may be as good it gets," Sharma tells investors in a research note. Due to an "unfavorable" sales/product mix and emerging competition in the U.S. from Bang, as well as "disappointing" margin progression abroad, the analyst sees limited ability for the company to meaningfully exceed expectations and justify a higher valuation multiple. Red Bull is not following Monster on its recent price and also appears to be expanding its price cuts to the larger single-serve segment in Walmart (WMT), the analyst contends. Further, he points out that Bang is now capturing nearly 40% of energy drinks growth. Lastly, Sharma sees a "dwindling likelihood" of the "long-hoped-for" buyout of Monster Beverage by Coca-Cola (KO).
03/12/19
03/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Boeing (BA) downgraded to Hold from Buy at Edward Jones. 2. Monster Beverage (MNST) downgraded to Market Perform from Outperform at BMO Capital with analyst Amit Sharma saying Monster's current valuation, both absolute and relative to peers, "may be as good it gets." 3. Coca-Cola (KO) downgraded to Hold from Buy at HSBC with analyst Carlos Laboy saying in "trying to grow the pie," Coke is being required to drive revenues with low-margin brands that may take years to scale up. 4. HP Enterprise (HPE) downgraded to Sell from Neutral at UBS with analyst John Roy saying the company's on-premises hardware sales are being pressured by the growth in public cloud, while the "stock is expecting better." 5. F5 Networks (FFIV) downgraded to Neutral from Overweight at JPMorgan with analyst Samik Chatterjee saying the "expensive" acquisition of NGINX is "tough to digest" given the integration and execution risk. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

VIA

Viacom

$25.14

-0.615 (-2.39%)

, VIAB

Viacom

$22.04

-0.52 (-2.31%)

09:11
11/14/19
11/14
09:11
11/14/19
09:11
Hot Stocks
Viacom: 'We're making enough TV to supply our needs, 3rd-parties' »

Viacom management said…

VIA

Viacom

$25.14

-0.615 (-2.39%)

VIAB

Viacom

$22.04

-0.52 (-2.31%)

CBS

CBS

$36.84

-0.935 (-2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 09

    Dec

ZEAL

Zealand Pharma

$31.60

-0.05 (-0.16%)

09:11
11/14/19
11/14
09:11
11/14/19
09:11
Hot Stocks
Breaking Hot Stocks news story on Zealand Pharma »

Zealand Pharma expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

GCI

Gannett

$9.84

-0.2 (-1.99%)

, NEWM

New Media

$6.69

-0.455 (-6.37%)

09:11
11/14/19
11/14
09:11
11/14/19
09:11
Conference/Events
Breaking Conference/Events news story on Gannett, New Media 

New Media

GCI

Gannett

$9.84

-0.2 (-1.99%)

NEWM

New Media

$6.69

-0.455 (-6.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

SAFM

Sanderson Farms

$159.66

-2.11 (-1.30%)

, TSN

Tyson Foods

$88.84

-0.155 (-0.17%)

09:10
11/14/19
11/14
09:10
11/14/19
09:10
Upgrade
Sanderson Farms, Tyson Foods, Pilgrim's Pride rating change  »

Sanderson Farms upgraded…

SAFM

Sanderson Farms

$159.66

-2.11 (-1.30%)

TSN

Tyson Foods

$88.84

-0.155 (-0.17%)

PPC

Pilgrim's Pride

$31.94

-0.34 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 04

    Dec

ZEAL

Zealand Pharma

$31.60

-0.05 (-0.16%)

09:10
11/14/19
11/14
09:10
11/14/19
09:10
Hot Stocks
Zealand Pharma 'on track' for HypoPal NDA submission in early 2020 »

Primary and all key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ZEAL

Zealand Pharma

$31.60

-0.05 (-0.16%)

09:09
11/14/19
11/14
09:09
11/14/19
09:09
Earnings
Zealand Pharma reports 9M revenue $4.4M vs. $3.9M last year »

Emmanuel Dulac, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

WW

WW

$35.14

0.6 (1.74%)

09:08
11/14/19
11/14
09:08
11/14/19
09:08
Conference/Events
WW management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 12

    Dec

OPTT

Ocean Power

$1.50

0.005 (0.34%)

09:08
11/14/19
11/14
09:08
11/14/19
09:08
Conference/Events
Ocean Power to host business news update conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$0.69

-0.103 (-13.03%)

09:07
11/14/19
11/14
09:07
11/14/19
09:07
Syndicate
Lipocine 10.45M share Secondary priced at 50c »

Roth Capital acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

EXPI

eXp World Holdings

$10.05

0.09 (0.90%)

09:07
11/14/19
11/14
09:07
11/14/19
09:07
Hot Stocks
eXp opens for business in the United Kingdom »

eXp, The Real Estate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

OSTK

Overstock.com

$8.12

0.37 (4.77%)

09:06
11/14/19
11/14
09:06
11/14/19
09:06
Hot Stocks
Medici Ventures joins Sovrin Alliance to promote self-sovereign identity »

Medici Ventures has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

TSEM

TowerJazz

$23.27

0.26 (1.13%)

09:06
11/14/19
11/14
09:06
11/14/19
09:06
Recommendations
TowerJazz analyst commentary  »

TowerJazz price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOVX

GeoVax Labs

$0.00

(0.00%)

09:05
11/14/19
11/14
09:05
11/14/19
09:05
Hot Stocks
GeoVax Labs to present at Vaccines R&D Conference »

GeoVax Labs announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$147.33

0.22 (0.15%)

, CRM

Salesforce

$162.61

-0.28 (-0.17%)

09:05
11/14/19
11/14
09:05
11/14/19
09:05
Hot Stocks
Microsoft, Salesforce expand strategic partnership »

Microsoft (MSFT) and…

MSFT

Microsoft

$147.33

0.22 (0.15%)

CRM

Salesforce

$162.61

-0.28 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 20

    Nov

  • 03

    Dec

  • 04

    Dec

  • 09

    Dec

  • 16

    Dec

GOOS

Canada Goose

$34.81

-4.245 (-10.87%)

09:04
11/14/19
11/14
09:04
11/14/19
09:04
Recommendations
Canada Goose analyst commentary  »

Canada Goose price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KIDS

OrthoPediatrics

$38.70

(0.00%)

09:04
11/14/19
11/14
09:04
11/14/19
09:04
Recommendations
OrthoPediatrics analyst commentary  »

OrthoPediatrics growth of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHAK

Shake Shack

$61.80

-1.49 (-2.35%)

, GRUB

GrubHub

$36.63

-0.7 (-1.88%)

09:04
11/14/19
11/14
09:04
11/14/19
09:04
Hot Stocks
Shake Shack begins nationwide delivery with GrubHub »

On November 14, Shake…

SHAK

Shake Shack

$61.80

-1.49 (-2.35%)

GRUB

GrubHub

$36.63

-0.7 (-1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WD

Walker & Dunlop

$64.94

-1.13 (-1.71%)

09:04
11/14/19
11/14
09:04
11/14/19
09:04
Conference/Events
Walker & Dunlop management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 04

    Dec

LGF.A

Lionsgate

$9.36

-0.34 (-3.51%)

, LGF.B

Lionsgate

$8.71

-0.38 (-4.18%)

09:02
11/14/19
11/14
09:02
11/14/19
09:02
Hot Stocks
Lionsgate, Amazon.com enter UK output deal »

Amazon (AMZN) announced…

LGF.A

Lionsgate

$9.36

-0.34 (-3.51%)

LGF.B

Lionsgate

$8.71

-0.38 (-4.18%)

AMZN

Amazon.com

$1,753.84

-24.49 (-1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

ARNA

Arena Pharmaceuticals

$46.27

0.09 (0.19%)

09:02
11/14/19
11/14
09:02
11/14/19
09:02
Hot Stocks
Everest Medicine announces first patient dosed in etrasimod Phase 3 study »

Everest Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRFH

Barfresh Food Group

$0.00

(0.00%)

09:02
11/14/19
11/14
09:02
11/14/19
09:02
Conference/Events
Barfresh Food Group to host conference call »

CEO Delle Coste,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

RBBN

Ribbon Communications

$4.05

-0.04 (-0.98%)

09:01
11/14/19
11/14
09:01
11/14/19
09:01
Hot Stocks
Ribbon Communications announces departure of CEO Franklin Hobbs »

Ribbon Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IONS

Ionis Pharmaceuticals

$57.61

0.6 (1.05%)

, BIIB

Biogen

$281.71

-9.67 (-3.32%)

09:00
11/14/19
11/14
09:00
11/14/19
09:00
Initiation
Ionis Pharmaceuticals, Biogen, Novartis, Roche initiated  »

William Blair says Ionis…

IONS

Ionis Pharmaceuticals

$57.61

0.6 (1.05%)

BIIB

Biogen

$281.71

-9.67 (-3.32%)

NVS

Novartis

$89.90

0.615 (0.69%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

SPR

Spirit AeroSystems

$89.29

0.42 (0.47%)

09:00
11/14/19
11/14
09:00
11/14/19
09:00
Conference/Events
Spirit AeroSystems management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TLRY

Tilray

$20.96

-0.61 (-2.83%)

09:00
11/14/19
11/14
09:00
11/14/19
09:00
Recommendations
Tilray analyst commentary  »

Tilray price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.